These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11502960)

  • 1. Donor or recipient origin of posttransplantation lymphoproliferative disorders: the traces of the Epstein-Barr virus.
    Volk HD; Babel N; Reinke P
    Transplantation; 2001 Aug; 72(3):361-2. PubMed ID: 11502960
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of Epstein-Barr virus load].
    Dehée A
    Ann Biol Clin (Paris); 2001 Oct; 59 Spec No():28-33. PubMed ID: 11675291
    [No Abstract]   [Full Text] [Related]  

  • 3. Epstein-Barr virus and posttransplant lymphoproliferative disease.
    Holmes R
    J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):442-4. PubMed ID: 11698760
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants].
    Hidalgo M; Lumbreras C; Aguado JM
    Med Clin (Barc); 1996 Sep; 107(8):310-6. PubMed ID: 8965496
    [No Abstract]   [Full Text] [Related]  

  • 5. Reactive Epstein-Barr virus-related polyclonal lymphoproliferative disorder in a patient with AIDS.
    Martin SI; Zukerberg L; Robbins GK
    Clin Infect Dis; 2005 Oct; 41(8):e76-9. PubMed ID: 16163622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.
    Haque T; Crawford DH
    Springer Semin Immunopathol; 1998; 20(3-4):375-87. PubMed ID: 9870252
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytomegalovirus and Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation.
    Tsao SY; Chang KC; Chen YP; Yeh YM; Su WC; Chen TY
    Ann Hematol; 2011 Jan; 90(1):113-4. PubMed ID: 20369358
    [No Abstract]   [Full Text] [Related]  

  • 8. Posttransplant lymphoproliferative disease, monoclonal, Epstein-Barr virus related.
    Petrovic LM
    Liver Transpl; 2001 May; 7(5):451-2. PubMed ID: 11349267
    [No Abstract]   [Full Text] [Related]  

  • 9. Pretransplantation assessment of the risk of lymphoproliferative disorder.
    Walker RC; Marshall WF; Strickler JG; Wiesner RH; Velosa JA; Habermann TM; McGregor CG; Paya CV
    Clin Infect Dis; 1995 May; 20(5):1346-53. PubMed ID: 7620022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplantation lymphoproliferative disorders (PTLD): current perspectives.
    Nalesnik MA
    Semin Thorac Cardiovasc Surg; 1996 Apr; 8(2):139-48. PubMed ID: 8672567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epstein-Barr virus and post-transplantation lymphoproliferations].
    Leblond V
    Ann Med Interne (Paris); 1997; 148(5):376-8. PubMed ID: 9538412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations among Epstein-Barr virus subtypes, human leukocyte antigen class I alleles, and the development of posttransplantation lymphoproliferative disorder in bone marrow transplant recipients.
    Görzer I; Puchhammer-Stöckl E; van Esser JW; Niesters HG; Cornelissen JJ
    Clin Infect Dis; 2007 Mar; 44(5):693-5. PubMed ID: 17278061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent increased Epstein-Barr virus loads after solid organ transplantation: truth and consequences?
    Green M; Webber SA
    Liver Transpl; 2007 Mar; 13(3):321-2. PubMed ID: 17318870
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical usefulness of Epstein-Barr viral load in solid-organ transplantation.
    Buteau C; Paya CV
    Liver Transpl; 2001 Feb; 7(2):157-9. PubMed ID: 11172403
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab.
    Maldonado NI; Cabanillas F; Jaffe ES; Raffeld M; Lozada L
    J Clin Oncol; 2011 Aug; 29(22):e658-60. PubMed ID: 21646613
    [No Abstract]   [Full Text] [Related]  

  • 16. Performance characteristics of two real-time PCR assays for the quantification of Epstein-Barr virus DNA.
    Hill CE; Harris SB; Culler EE; Zimring JC; Nolte FS; Caliendo AM
    Am J Clin Pathol; 2006 May; 125(5):665-71. PubMed ID: 16707366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of semiquantitative polymerase chain reaction for Epstein-Barr virus to measure virus load in pediatric organ transplant recipients with and without posttransplant lymphoproliferative disease.
    Allen U; Hebert D; Petric M; Tellier R; Tran D; Superina R; Stephens D; West L; Wasfy S; Nelson S
    Clin Infect Dis; 2001 Jul; 33(2):145-50. PubMed ID: 11418872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder.
    Humar A; Hébert D; Davies HD; Humar A; Stephens D; O'Doherty B; Allen U
    Transplantation; 2006 Mar; 81(6):856-61. PubMed ID: 16570008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus lymphoproliferative disease of donor origin after kidney transplantation: a case report.
    Renoult E; Aymard B; Grégoire MJ; Bellou A; Hubert J; Hestin D; Audouin J; Lederlin P; Kessler M
    Am J Kidney Dis; 1995 Jul; 26(1):84-7. PubMed ID: 7611274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients.
    Preiksaitis JK
    Clin Infect Dis; 2004 Oct; 39(7):1016-23. PubMed ID: 15472855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.